Interleukin 1β, interleukin 6, tumor necrosis factor α, and interleukin 10 responses in peripheral blood mononuclear cells of cynomolgus macaques during acute infection with SIVmac251

AIDS Research and Human Retroviruses

Volumn 12, Issue 3, 1996, Pages 241-250

  Benveniste, Olivier ^a   Vaslin, Bruno ^a   Le Grand, Roger ^a   Fouchet, Pierre ^a   Omessa, Valérie ^a   Theodoro, Frederic ^a   Fretier, Philippe ^a   Clayette, Pascal ^a   Boussin, François ^a   Dormont, Dominique ^a  

^a DSV/DRM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INOCULATION; LYMPHOCYTE COUNT; MACACA; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE SUBPOPULATION; VIREMIA;

EID: 0030058027     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.241     Document Type: Article

References (50)

1. Levy JA: Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993;57:183-289.
2. Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vézinet-Brun F, Rouzioux C, Rozenbaum W, and Montagnier L: Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868-871.
3. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, and Ho DD: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994; 68:4650-4655.
4. Reimann KA, Tenner-Racz K, Racz P, Montefiori DC, Yasutomi Y, Lin W, Ransil BJ, and Letvin NL: Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Virol 1994;68:2362-2370.
5. Clerici M, Giorgi JV, Chou CC, Gudeman VK, Zack JA, Gupta P, Ho HN, Nishanian PG, Berzofsky JA, and Shearer GM: Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992;165:1012-1019.
6. Clerici M, Hakim FT, Venzon DJ, Blatt S, Hendrix CW, Wynn TA, and Shearer GM: Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 1993;91:759-765.
7. Osborn L, Kunkel S, and Nabel GJ: Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc Natl Acad Sci USA 1989;86:2336-2340.
8. Le Naour R, Clayette P, Mabondzo A, Raoul H, Bousseau A, and Dormont D: Infection of human macrophages with an endogenous tumor necrosis factor-alpha (TNF-α)-independent human immunodeficiency virus type 1 isolate is unresponsive to the TNF-α synthesis inhibitor RP 55778. J Gen Virol 1994;75:1379-1388.
9. Le Naour R, Raoul H, Mabondzo A, Ripoll L, Batholeyns J, Romet-Lemonne JL, and Dormont D: Functional consequences of monocyte/macrophage infection by HIV-1. Res Immunol 1992; 143:49-56.
10. Weissman D, Poli G, and Fauci AS: Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor α and interleukin 6 induction of virus. AIDS Res Hum Retroviruses 1994;10:1199-1206.
11. Koostra NA, van't Wout AB, Huisman HG, Miedema F, and Schuitemaker H: Interference of interleukin-10 with human immunodeficiency virus type 1 replication in primary monocyte-derived macrophages. J Virol 1994;68:6967-6975.
12. Chollet-Martin S, Simon F, Matheron S, Joseph CA, Elbim C, and Gougerot-Pocidalo MA: Comparison of plasma cytokine levels in African patients with HIV-1 and HIV-2 infection. AIDS 1994;8:879-884.
13. Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Dierich MP, and Wachter H: Interferon-γ concentrations are increased in sera from individuals infected with human immunodeficiency virus type 1. J Acquir Immune Defic Syndr 1989; 2:158-162.
14. Voth R, Rossol S, Klein K, Hess G, Schütt KH, Schröder HC, Meyer zum Büschenfelde KH, and Müller WE: Differential gene expression of IFN-α and tumor necrosis factor-α in peripheral blood mononuclear cells from patients with AIDS related complex and AIDS. J Immunol 1990;144:970-975.
15. Scott-Algara D, Vuillier F, Marasescu M, de Saint Martin J, and Dighiero G: Serum levels of IL-2, IL-1α, TNF-α, and soluble receptor of IL-2 in HIV-1 infected patients. AIDS Res Hum Retroviruses 1991;7:381-386.
16. Israël-Biet D, Cadranel J, Beldjord K, Andrieu JM, Jeffrey A, and Even P: Tumor necrosis factor production in HIV-seropositive subjects. Relationship with lung opportunistic infections and HIV expression in alveolar macrophages. J Immunol 1991;147:490-494.
17. Hess G, Rossol S, Rossol R, and Meyer zum Büschenfelde KH: Tumor necrosis factor and interferon as prognostic markers in human immunodeficiency virus (HIV) infection. Infection 1991; 19(Suppl. 2):S93-S97.
18. Reddy MM, Sorrell SJ, Lange M, and Grieco MH: Tumor necrosis factor and HIV p24 antigen levels in serum of HIV-infected populations. J Acquir Immune Defic Syndr 1988;1:436-440.
19. Lähdevirta J, Maury CP, Teppo AM, and Repo H: Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988;85:289-291.
20. Matsuyama T, Kobayashi N, and Yamamoto N: Cytokines and HIV infection: Is AIDS a tumor necrosis factor disease? AIDS 1991; 5:1405-1417.
21. Breen EC, Rezai AR, Nakajima K, Beall GN, Mitsuyasu RT, Hirano T, Kishimoto T, and Martinez-Maza O: Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990;144:480-484.
22. Fan J, Bass HZ, and Fahey JL: Elevated IFN-γ and decreased IL-2 gene expression are associated with HIV infection. J Immunol 1993;151:5031-5040.
23. Rautonen J, Rautonen N, Martin NL, Philip R, and Wara DW: Serum interleukin-6 concentrations are elevated and associated with elevated tumor necrosis factor-α and immunoglobulin G and A concentrations in children with HIV infection. AIDS 1991; 5:1319-1325.
24. Graziosi C, Pantaleo G, Gantt KR, Fortin JP, Demarest JF, Cohen OJ, Sékaly RP, and Fauci AS: Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science 1994;265:248-252.
25. Sinicco A, Biglino A, Sciandra M, Forno B, Pollono AM, Raiteri R, and Gioannini P: Cytokine network and acute primary HIV-1 infection. AIDS 1993;7:1167-1172.
26. von Sydow M, Sönnerborg A, Gaines H, and Strannegård Ö: Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. AIDS Res Hum Retroviruses 1991;7:375-380.
27. Desrosiers RC: The simian immunodeficiency viruses. Annu Rev Immunol 1990;8:557-578.
28. Le Grand R, Clayette P, Noack O, Vaslin B, Theodoro F, Michel G, Roques P, and Dormont D: An animal model for anti-lentiviral therapy: Effect of zidovudine on viral load during acute infection after exposure of macaques to the simian immunodeficiency. AIDS Res Hum Retroviruses 1994;10:1279-1287.
29. Journal Officiel des Communautés Européennes, L358, December 18, 1986.
30. Le Grand R, Vaslin B, Vogt G, Roques P, Humbert M, Aubertin AM, and Dormont D: AIDS vaccine developments [letter, comment]. Nature (London) 1992;355:684.
31. Le Grand R, Vogt G, Vaslin B, Roques P, Théodoro F, Aubertin AM, and Dormont D: Specific and non-specific immunity and protection of macaques against SIV infection. Vaccine 1992; 10:873-879.
32. Vaslin B, Le Grand R, Vogt G, Benveniste O, Gras G, Roques P, Stoeckel P, Salk PL, Salk J, and Dormont D: Induction of humoral and cellular immunity to simian immunodeficiency virus: What are the requirements for protection? Vaccine 1994;12:1132-1140.
33. Kärber G: Beitrag zur kollektiven Behandlung Pharmakologischer Reihenvesuche. Arch Exp Pathol Pharmak 1931;162:956-959.
34. Erkeller-Yuksel FM, Deneys V, Yuksel B, Hannet I, Hulstaert F, Hamilton C, Mackinnon H, Turner Stokes L, Munhyeshuli V, Vanlangendonck F, De Bruyère M, and Bach BA: Age-related changes in human blood lymphocyte subpopulations. J Pediatr 1992;120:216-222.
35. Villinger F, Hunt D, Mayne A, Vuchetich M, Findley H, and Ansari AA: Qualitative and quantitative studies of cytokines synthesized and secreted by non-human primate peripheral blood mononuclear cells. Cytokine 1993;5:469-479.
36. Glazer AN and Rye HS: Stable dye-DNA intercalation complexes as reagents for high-sensitivity flurescence detection. Nature (London) 1992;359:859-861.
37. Clayette P, Le Grand R, Noack O, Vaslin B, Le Naour R, Benveniste O, Théodoro F, Frétier P, and Dormont D: Tumor necrosis factor-alpha in serum of macaques during SIVmac251 acute infection. J Med Primatol 1995;24:94-100.
38. smm/PBj-14 in pig-tailed macaques. AIDS Res Hum Retroviruses 1993; 9:1123-1129.
39. Schwiebert R and Fultz PN: Immune activation and viral burden in acute disease induced by simian immunodeficiency virus PBj14: Correlation between in vitro and in vivo events. J Virol 1994; 68:5538-5547.
40. Fultz PN, McClure HM, Anderson DC, and Switzer WM: Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM). AIDS Res Hum Retroviruses 1989;5:397-409.
41. Hurtrel B, Chakrabarti L, Khatissian E, and Montagnier L: 1st International Symposium on HIV and Cytokines, March 1995, Reims, France, Abstract C8.
42. Ameglio F, Capobianchi MR, Castilletti C, Cordiali Fei P, Fais S, Trento E, and Dianzani F: Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells; correlation with the induction of other cytokines. Clin Exp Immunol 1994;95:455-458.
43. Lafeuillade A, Poizot-Martin I, Quilichini R, Gastaut JA, Kaplanski S, Farnarier C, Mege JL, and Bongrand P: Increased interleukin-6 production is associated with disease progression in HIV infection [letter]. AIDS 1991;5:1139-1140.
44. Steffen M, Reinecker HC, Petersen J, Doehn C, Pfluger I, Voss A, and Raedler A: Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-infected patients. Clin Exp Immunol 1993; 91:30-36.
45. Ramsay AJ, Husband AJ, Ramshaw IA, Bao S, Matthaei KI, Koehler G, and Kopf M: The role of IL-6 in mucosal IgA antibody responses in vivo. Science 1994;264:561-563.
46. Akira S and Kishimoto T: IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 1992;127:25-50.
47. Aderka D, Holtmann H, Toker L, Hahn T, and Wallach D: Tumor necrosis factor induction by Sendai virus. J Immunol 1986; 136:2938-2942.
48. de Waal Malefyt R, Yssel H, Roncarolo MG, Spits H, and de Vries JE: Interleukin-10. Curr Opin Immunol 1992;4:314-320.
49. Sieling PA, Abrams JS, Yamamura M, Salgame P, Bloom BR, Rea TH, and Modlin RL: Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol 1993;150:5501-5510.
50. Clerici M, Wynn TA, Berzofsky JA, Blatt SP, Henrix CW, Sher A, Coffman RL, and Shearer GM: Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 1994;93: 768-775.